2017
The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice
Abstract: Summary Glucagon-like peptide 1 (GLP-1) is necessary for normal gluco-regulation, and it has been widely presumed that this function reflects the actions of GLP-1 released from enteroendocrine L-cells. To test the relative importance of intestinal vs. pancreatic sources of GLP-1 for physiological regulation of glucose, we administered a GLP-1R antagonist, exendin 9–39 (Ex9), to mice with tissue-specific reactivation of the preproglucagon gene (Gcg). Ex9 impaired glucose tolerance in wild-type mice but had no i…
Search citation statements
Paper Sections
Select...
159
38
34
17
Citation Types
26
205
3
0
Year Published
2009
2026
Publication Types
Select...
198
12
8
6
Relationship
22
202
Authors
Journals
Cited by 210 publications
(235 citation statements)
References 30 publications
26
205
3
0
“…To validate these findings in the inducible model, Ex9, or saline (Sal) was injected 15 minutes before a glucose gavage ( Figure 1, C and D). Similar to our previous finding (18), glucose levels were significantly higher after Ex9 in control VilCreERT2 mice but had no effect on glucose levels in the GcgRA ΔVilCreERT2 mice. These data indicate intestinally secreted GLP-1 does not regulate glucose tolerance in mice under these conditions and replicates our previous data.…”
Section: Resultssupporting
confidence: 91%
“…To validate these findings in the inducible model, Ex9, or saline (Sal) was injected 15 minutes before a glucose gavage ( Figure 1, C and D). Similar to our previous finding (18), glucose levels were significantly higher after Ex9 in control VilCreERT2 mice but had no effect on glucose levels in the GcgRA ΔVilCreERT2 mice. These data indicate intestinally secreted GLP-1 does not regulate glucose tolerance in mice under these conditions and replicates our previous data.…”
Section: Resultssupporting
confidence: 91%
“…Ex9 and linagliptin administered together to VilCre control mice but not GcgRA ΔVilCre or GcgRA ΔNull mice produced elevated basal glucose (−15 min) and all mice had a significantly lower glucose excursion compared with Ex9 treatment alone at 15-60 min after the glucose load. These findings are consistent with our previous findings [9] but do not fit with the conventional model, whereby GLP-1 secreted into the circulation from the gut mediates the effects of DPP-4 inhibitor action [13].…”
Section: Resultssupporting
confidence: 89%
“…It is curious if this phenomenon is present in islet β-cells in vivo. Consistent with our data, recent studies showed that intraislet GLP-1 and/or glucagon are essential for maintaining proper β-cell responsiveness to glucose and regulating glucose homeostasis 37 – 41 . Glucagon was shown to bind to GLP-1 receptors and elevate cAMP levels of β-cells.…”
Section: Discussionsupporting
confidence: 93%
